Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): A 2 × 2 factorial randomised trial

The Lancet Psychiatry

Volumn 3, Issue 1, 2016, Pages 31-39

  Geddes, John R ^a   Gardiner, Alexandra ^a,b   Rendell, Jennifer ^a   Voysey, Merryn ^b   Tunbridge, Elizabeth ^a   Hinds, Christopher ^a   Yu, Ly Mee ^b   Hainsworth, Jane ^a   Attenburrow, Mary Jane ^a   Simon, Judit ^c   Goodwin, Guy M ^a   Harrison, Paul J ^a  

^a WARNEFORD HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; LAMOTRIGINE; PLACEBO; QUETIAPINE; NEUROLEPTIC AGENT; TRIAZINE DERIVATIVE;

ADOLESCENT; ADULT; ALGORITHM; ARTICLE; ASSESSMENT OF HUMANS; BIPOLAR DEPRESSION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DSM-IV; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARALLEL DESIGN; QUICK INVENTORY OF DEPRESSIVE SYMPTOMATOLOGY SELF REPORT VERSION 16; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNITED KINGDOM; BIPOLAR DISORDER; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; MIDDLE AGED;

ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FOLIC ACID; HUMANS; MALE; MIDDLE AGED; QUETIAPINE FUMARATE; TREATMENT OUTCOME; TRIAZINES;

EID: 84953368194     PISSN: 22150366     EISSN: 22150374     Source Type: Journal    
DOI: 10.1016/S2215-0366(15)00450-2     Document Type: Article

References (28)

1. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015, 386:743-800. Global Burden of Disease Study 2013 Collaborators.
2. Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002, 59:530-537.
3. Geddes JR, Miklowitz DJ Treatment of bipolar disorder. Lancet 2013, 381:1672-1682.
4. Bipolar disorder: the management of bipolar disorder in adults, children and young people, in primary and secondary care 2014, National Collaborating Centre for Mental Health, National Institute for Health and Clinical Excellence, London, (accessed Nov 13, 2015). https://www.nice.org.uk/guidance/cg185.
5. Sidor MM, MacQueen GM An update on antidepressant use in bipolar depression. Curr Psychiatry Rep 2012, 14:696-704.
6. Brodie MJ Lamotrigine. Lancet 1992, 339:1397-1400.
7. Weisler RH, Calabrese JR, Bowden CL, Ascher JA, DeVeaugh-Geiss J, Evoniuk G Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence. J Affect Disord 2008, 108:1-9.
8. Goodwin GM, Bowden CL, Calabrese JR, et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 2004, 65:432-441.
9. Geddes JR, Calabrese JR, Goodwin GM Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry 2009, 194:4-9.
10. Van der Loos MLM, Mulder PGH, Hartong EGTM, et al. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. J Clin Psychiatry 2009, 70:223-231.
11. Taylor MJ, Carney SM, Goodwin GM, Geddes JR Folate for depressive disorders: systematic review and meta-analysis of randomized controlled trials. J Psychopharmacol 2004, 18:251-256.
12. Harden CL, Pennell PB, Koppel BS, et al. Management issues for women with epilepsy-focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding. Epilepsia 2009, 50:1247-1255.
13. Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, American Psychiatric Association, Washington DC. 4th edn.
14. US Food and Drug Administration LAMICTAL prescribing information, (accessed Nov 13, 2015). http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020241s037s038,020764s030s031lbl.pdf.
15. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003, 54:573-583.
16. Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T The inventory of depressive symptomatology, clinician rating (IDS-C) and self-report (IDS-SR), and the quick inventory of depressive symptomatology, clinician rating (QIDS-C) and self-report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 2004, 34:73-82.
17. Bernstein IH, Rush AJ, Suppes T, Kyotoku Y, Warden D The quick inventory of depressive symptomatology (clinician and self-report versions) in patients with bipolar disorder. CNS Spectr 2010, 15:367-373.
18. Bernstein IH, Rush AJ, Suppes T, et al. A psychometric evaluation of the clinician-rated Quick Inventory of Depressive Symptomatology (QIDS-C16) in patients with bipolar disorder. Int J Methods Psychiatr Res 2009, 18:138-146.
19. Altman EG, Hedeker D, Peterson JL, Davis JM The Altman self-rating mania scale. Biol Psychiatry 1997, 42:948-955.
20. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208. EuroQol Group.
21. Bopp JM, Miklowitz D, Geddes JR, Goodwin GM, Rendell J, Stevens W Text messaging based mood charting for individuals with bipolar disorder 2008, Association for Behavioral and Cognitive Therapies, Orlando, FL.
22. Pablos MA, Barr RG, Shea S Run-in periods in randomized trials: implications for the application of results in clinical practice. JAMA 1998, 279:222-225.
23. Suppes T, Vieta E, Liu S, Brecher M, Paulsson B, Trial I Maintenance treatment for patients with bipolar I disorder: results from a north American study of quetiapine in combination with lithium or divalproex (Trial 127). Am J Psychiatry 2009, 166:476-488.
24. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988, 2:349-360.
25. McAlister FA, Straus SE, Sackett DL, Altman DG Analysis and reporting of factorial trials: a systematic review. JAMA 2003, 289:2545-2553.
26. Lubsen J, Pocock SJ Factorial trials in cardiology: pros and cons. EurHeart J 1994, 15:585-588.
27. Crider KS, Bailey LB, Berry RJ Folic acid food fortification-its history, effect, concerns, and future directions. Nutrients 2011, 3:370-384.
28. Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord 2013, 15:1-44.